Is Hip Range of Motion Relevant in the Treatment of Chronic Low Back Pain?

University of Jaén

Status

Completed

Conditions

Chronic Low-back Pain

Treatments

Other: Control group

Other: Intervention group

Study type

Interventional

Funder types

Other

Identifiers

NCT05328063

CEIM/2022/1/002

Details and patient eligibility

About

The study will be carried out at the Faculty of Nursing and Physiotherapy of the University of Alcalá. The study has been approved by the Animal Research and Experimentation Ethics Committee of the University of Alcalá. A total of 60 subjects aged between 18 and 35 with non.specific low back pain will be selected and randomized in two interventions.

The control group will carry out a specific strengthening program for the gluteus maximus and the experimental group will carry out the same strengthening program in addition to receiving a specific manual therapy program for both hips.

The total duration of the treatments will be 8 weeks, with on-treatment evaluations at 4 and 8 weeks, with a follow-up after 1 month.

The objective will be to determine the efficacy of manual therapy on the coxofemoral joint together with a protocol of gluteus maximus strengthening exercises in patients with non-specific chronic low back pain, in comparison with the same protocol of gluteus maximus strengthening exercises performed in isolation, in patients with non-specific chronic low back pain.

Full description

Detailed Description has not been entered.

Enrollment

60 patients

Sex

All

Ages

18 to 35 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients with non-specific low back pain, with a score of more than 2 on the visual analogue scale.
Pain with a course of more than 12 weeks, of a chronic nature.

Exclusion criteria

Patients with neurological signs and symptoms or severe psychiatric illnesses.
Subjects with a history of severe trauma, fracture or previous surgery on the lumbar spine or hip.
Subjects with a history of musculoskeletal and/or rheumatologic disease.
Patients with low back pain attributable to dysmenorrhoea.
Pregnant patients.
Individuals with fibromyalgia, autoimmune disorders.
Subjects with a history of oncological processes.